Subscribe
Share
Share
Embed
In this special episode, the tables are turned and Professor David Nutt is interviewed by singer-songwriter and podcast host - Joss Stone about Neuropsychopharmacology.
The tables have been turned in this one-off special of the Drug Science podcast. In this episode, Professor David Nutt is interviewed by renowned singer-songwriter – Joss Stone. Professor Nutt is the Chair of the Drug Science Scientific Committee and currently the Edmund J Safra Professor of Neuropsychopharmacology and Head of the Neuropsychopharmacology Unit at Imperial College London. Professor Nutt has steered the psychedelic renaissance toward legitimate research in the UK enabling the next generation of researchers to expand our understanding of these substances.
In this week’s episode, Professor Nutt is interviewed by singer-songwriter Joss Stone. Joss became a friend of the show after appearing in our first season of the podcast to talk about Medical Cannabis. Now she’s back to ask the Professor some burning questions about cannabis, psychedelics, SSRI’s, Adderall, addiction and pain.
Prescribed CBD could help people quit cannabis
Medical Psychedelics Working Group
Become a Drug Science Community Member: https://www.donate.drugscience.org.uk/
Twitter: @ProfDavidNutt @Drug_Science
A Fascinate Productions podcast for Drug Science
★ Support this podcast ★Professor David Nutt has spent a career making the argument for a rational, evidence-based approach to drug policy and drug use. The scientific evidence still challenges perceived wisdom on drugs and for that reason can appear to be contentious. In this podcast, the Professor explores the actual harms and potential benefits of various drugs, challenging myths surrounding classification and legislation, and exploring the societal impact of poorly informed drug policy. Using evidence in public policy should not be controversial. A podcast for anyone interested in understanding the scientific truth about drugs, free from political or moral concern.